Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor.
Prokhnevska N, Cardenas MA, Valanparambil RM, Sobierajska E, Barwick BG, Jansen C, Reyes Moon A, Gregorova P, delBalzo L, Greenwald R, Bilen MA, Alemozaffar M, Joshi S, Cimmino C, Larsen C, Master V, Sanda M, Kissick H. Prokhnevska N, et al. Among authors: joshi s. Immunity. 2023 Jan 10;56(1):107-124.e5. doi: 10.1016/j.immuni.2022.12.002. Epub 2022 Dec 28. Immunity. 2023. PMID: 36580918 Free PMC article.
Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database.
Janopaul-Naylor JR, Zhong J, Liu Y, Zhang C, Osunkoya AO, Joshi SS, Bilen MA, Carthon B, Kucuk O, Hartsell LM, Shelton J, Jani AB. Janopaul-Naylor JR, et al. Clin Transl Radiat Oncol. 2020 Nov 9;26:30-34. doi: 10.1016/j.ctro.2020.11.002. eCollection 2021 Jan. Clin Transl Radiat Oncol. 2020. PMID: 33294644 Free PMC article.
Initial Report of a Randomized Trial Comparing Conventional- vs Conventional plus Fluciclovine (18F) PET/CT Imaging-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer.
Jani A, Schreibmann E, Goyal S, Raghuveer H, Hershatter B, Rossi PJ, Shelton JW, Patel PR, Xu KM, Goodman M, Master V, Joshi SS, Kucuk O, Carthon B, Bilen MA, Cooper S, Fielder B, Abiodun-Ojo O, Dhere VR, Schuster DM. Jani A, et al. Among authors: joshi ss. Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1397. doi: 10.1016/j.ijrobp.2020.09.018. Epub 2020 Nov 18. Int J Radiat Oncol Biol Phys. 2020. PMID: 33427655 No abstract available.
Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance.
Abiodun-Ojo OA, Jani AB, Akintayo AA, Akin-Akintayo OO, Odewole OA, Tade FI, Joshi SS, Master VA, Fielder B, Halkar RK, Zhang C, Goyal S, Goodman MM, Schuster DM. Abiodun-Ojo OA, et al. Among authors: joshi ss. J Nucl Med. 2021 Aug 1;62(8):1089-1096. doi: 10.2967/jnumed.120.256784. Epub 2021 Jan 30. J Nucl Med. 2021. PMID: 33517323 Free PMC article.
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
Brown JT, Liu Y, Shabto JM, Martini DJ, Ravindranathan D, Hitron EE, Russler GA, Caulfield S, Yantorni LB, Joshi SS, Kissick H, Ogan K, Harris WB, Carthon BC, Kucuk O, Master VA, Bilen MA. Brown JT, et al. Among authors: joshi ss. Oncologist. 2021 May;26(5):397-405. doi: 10.1002/onco.13727. Epub 2021 Mar 18. Oncologist. 2021. PMID: 33634507 Free PMC article.
18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial.
Jani AB, Schreibmann E, Goyal S, Halkar R, Hershatter B, Rossi PJ, Shelton JW, Patel PR, Xu KM, Goodman M, Master VA, Joshi SS, Kucuk O, Carthon BC, Bilen MA, Abiodun-Ojo OA, Akintayo AA, Dhere VR, Schuster DM. Jani AB, et al. Among authors: joshi ss. Lancet. 2021 May 22;397(10288):1895-1904. doi: 10.1016/S0140-6736(21)00581-X. Epub 2021 May 7. Lancet. 2021. PMID: 33971152 Free PMC article. Clinical Trial.
Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
Brown JT, Liu Y, Shabto JM, Martini D, Ravindranathan D, Hitron EE, Russler GA, Caulfield S, Yantorni L, Joshi SS, Kissick H, Ogan K, Nazha B, Carthon BC, Kucuk O, Harris WB, Master VA, Bilen MA. Brown JT, et al. Among authors: joshi ss. J Immunother Cancer. 2021 Jul;9(7):e002851. doi: 10.1136/jitc-2021-002851. J Immunother Cancer. 2021. PMID: 34326170 Free PMC article.
5,149 results